home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/9095d4c5-7bf9-4699-8499-7beee69d069d_Custom_Intelligence_Biosimilars_Whitepaper_LR.pdf
whitepaper
SHARESHARESHARE
BIOSIMILARS – COMMERCIAL BEST PRACTICES IN THE AGE OF SUSTAINABILITY
Revenues from biologics increased by 70% from 2011 to 2016. Biologics account for 20-22% of total pharmaceutical spending. IQVIA estimates US biologics spending will reach $320bn by 2023 DUNCAN EMERTON DOWNLOAD